Document is current
Any future updates will be listed below
-
Authors
Zhai, T. -S. https://orcid.org/0000-0002-1441-6256
Hu, L. -T.
Ma, W. -G.
Chen, X.
Luo, M.
Jin, L.
Zhou, Z.
Liu, X.
Kang, Y.
Kang, Y. -X.
Zhang, J. -X.
Liu, H.
Lu, J. -Y.
Yao, X. -D.
Ye, L.
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81672549, 81972409)
Natural Science Foundation of Shanghai (15ZR1433000, 17ZR1421800)
Karamay Municipal Science and Technology Foundation (JK2017-5)
Youth Subject of Karamay Central Hospital (QK2017-5)
Health System Independent Innovation Science Foundation of Shanghai Putuo District (ptkwws201819)
- License Information
-
More Information
Article History
Received: 19 March 2020
Accepted: 7 May 2020
First Online: 30 May 2020
Compliance with ethical standards
:
: Shanghai Tenth People’s Hospital, Tongji University School of Medicine has a pending patent for using PPAT measurements as diagnostic and prognostic biomarkers of prostate cancer in patients.
: Ethical approval was obtained from Human Research Ethics Committee, Shanghai Tenth People’s Hospital, Tongji University School of Medicine and the approval number is 2019-K-135.
: Written informed consent for participation was obtained from each study participant.
